Biocompatibility of silver containing silica films on Bioverit® II middle ear prostheses in rabbits
Source abstract
Abstract
For several centuries silver is known for its antibacterial effects. The middle ear is an interesting new scope for silver application since chronic inflammations combined with bacterial infection cause complete destruction of the fragile ossicle chain and tympanic membrane. The resulting conductive deafness requires tympanoplasty for reconstruction. Strategies to prevent bacterial growth on middle ear prostheses are highly recommended. In this study, rabbits were implanted with Bioverit® II middle ear prostheses functionalized with silver containing dense and nanoporous silica films which were compared with pure silica coatings as well as silver sulfadiazine cream applied on nanoporous silica coating. The health status of animals was continuously monitored; blood was examined before and after implantation. After 21 days, the middle ears were inspected; implants and mucosal samples were processed for electron microscopy. Autopsies were performed and systemic spreading of silver was chemically analyzed exemplarily in liver and kidneys. For verification of direct cytotoxicity, NIH 3T3 cells were cultured on similar silver containing silica coatings on glass up to 3 days. In vitro a reduced viability of fibroblasts adhering directly on the samples was detected compared to cells growing on the surrounding plastic of the same culture dish. In transmission electron microscopy, phagocytosed silver silica fragments, silver sulfadiazine cream as well as silver nanoparticles were noticed inside endosomes. In vivo, clinical and post mortem examinations were inconspicuous. Chemical analyses showed no increased silver content compared to controls. Mucosal coverages on almost all prostheses were found. But reduction of granulation tissue was only obvious around silver-coated implants. Single necroses and apoptosis in the mucosa were correlated by intracellular accumulation of metallic silver. For confirming supportive healing effects of middle ear implants, silver ion aggregates need to be tested in the future to optimize biocompatibility while assuring bactericidal effects in the middle ear.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Ear Surgery and Otitis Media · Dielectric properties of ceramics · Medicinal Plants and Neuroprotection
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
ENT Department, Hannover Medical School, Hannover, Germany
Institute for Laboratory Animal Science, Hannover Medical School, Hannover, Germany
Cluster of Excellence “Hearing4all”, Institute for Inorganic Chemistry, Leibniz Universität Hannover, Hannover, Germany
Institute of Zoology, University of Veterinary Medicine Hannover, Hannover, Germany
Institute of Cellular Biology in the Centre for Anatomy, Hannover Medical School, Hannover, Germany
References (76)
Show source-provided references
1. 10.1001/archotol.128.10.112910.1001/archotol.128.10.1129 ↗
2. 10.1016/j.otohns.2009.08.01010.1016/j.otohns.2009.08.010 ↗
3. 10.1016/S1043-1810(95)80003-410.1016/S1043-1810(95)80003-4 ↗
4. 10.1097/00129492-200103000-0000510.1097/00129492-200103000-00005 ↗
5. 10.1007/s00106005036310.1007/s001060050363 ↗
6. 10.1080/0001648060105303210.1080/00016480601053032 ↗
7. 10.1177/088532820809546910.1177/0885328208095469 ↗
8. 10.1039/c3cs35359a10.1039/c3cs35359a ↗
9. 10.1128/CMR.15.2.167-193.200210.1128/CMR.15.2.167-193.2002 ↗
10. 10.1039/b515219b10.1039/b515219b ↗
11. 10.1067/mhn.2001.11716310.1067/mhn.2001.117163 ↗
12. 10.1016/j.actbio.2012.08.01610.1016/j.actbio.2012.08.016 ↗
13. 10.1086/37484210.1086/374842 ↗
14. 10.1097/MAO.0b013e318283967110.1097/MAO.0b013e3182839671 ↗
15. 10.1007/s10856-012-4769-110.1007/s10856-012-4769-1 ↗
16. 10.1089/sur.2008.994110.1089/sur.2008.9941 ↗
17. Webster DA · Clin Orthop Relat Res · 1981 · 161 · 10510.1097/00003086-198111000-00013 ↗
18. 10.1007/s00192-010-1330-y10.1007/s00192-010-1330-y ↗
19. 10.1093/jac/dkn03410.1093/jac/dkn034 ↗
20. 10.1177/08853282940090010310.1177/088532829400900103 ↗
21. 10.1016/0022-4804(88)90116-310.1016/0022-4804(88)90116-3 ↗
22. 10.1007/s10856-013-5014-210.1007/s10856-013-5014-2 ↗
23. 10.1001/archinte.160.21.329410.1001/archinte.160.21.3294 ↗
24. 10.1021/nn102272n10.1021/nn102272n ↗
25. 10.1088/0957-4484/16/10/05910.1088/0957-4484/16/10/059 ↗
26. 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-310.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3 ↗
27. 10.1016/j.watres.2008.12.00210.1016/j.watres.2008.12.002 ↗
28. 10.1128/AEM.69.7.4278-4281.200310.1128/AEM.69.7.4278-4281.2003 ↗
29. 10.1002/anie.20120592310.1002/anie.201205923 ↗
30. 10.1016/S0195-6701(98)90301-210.1016/S0195-6701(98)90301-2 ↗
31. 10.1155/2010/91068610.1155/2010/910686 ↗
32. 10.1016/j.cca.2010.08.01610.1016/j.cca.2010.08.016 ↗
33. Chole RA · Am J Otol · 1995 · 16 · 722
34. 10.1001/archotol.1995.0189005005401010.1001/archotol.1995.01890050054010 ↗
35. 10.1055/s-2006-92520610.1055/s-2006-925206 ↗
36. 10.1002/cphc.20070079110.1002/cphc.200700791 ↗
37. 10.1088/0953-8984/9/34/01510.1088/0953-8984/9/34/015 ↗
38. 10.1023/A:102160800383610.1023/A:1021608003836 ↗
39. 10.1258/la.2008.00715210.1258/la.2008.007152 ↗
40. DIN 32645: 2008-11 · 2008
41. DIN 38402-51: 1986-05 · 1986
42. 10.1055/s-0028-111949310.1055/s-0028-1119493 ↗
43. 10.1055/s-2000-1591810.1055/s-2000-15918 ↗
44. 10.1007/s00418-009-0670-510.1007/s00418-009-0670-5 ↗
45. 10.1039/C0JM01487G10.1039/C0JM01487G ↗
46. 10.1016/j.taap.2009.02.02010.1016/j.taap.2009.02.020 ↗
47. 10.1016/j.actbio.2013.09.03710.1016/j.actbio.2013.09.037 ↗
48. 10.1002/jnr.2256910.1002/jnr.22569 ↗
49. 10.1111/j.1365-2133.1997.tb01109.x10.1111/j.1365-2133.1997.tb01109.x ↗
50. 10.1046/j.1524-475X.2002.10308.x10.1046/j.1524-475X.2002.10308.x ↗
51. Jahnke K · 1996 · 41
52. Zahnert T · Dtsch Arztebl Int · 2011 · 108 · 433
53. De Souza C · 2013 · 3
54. 10.1055/s-2007-99692810.1055/s-2007-996928 ↗
55. 10.3109/0001648860913283210.3109/00016488609132832 ↗
56. Arnold W · Arch Otorhinolaryngol · 1977 · 216 · 36910.1007/BF00455140 ↗
57. 10.1111/j.1742-7843.2010.00668.x10.1111/j.1742-7843.2010.00668.x ↗
58. 10.1016/j.heares.2005.10.01510.1016/j.heares.2005.10.015 ↗
59. 10.1039/c2ra20684f10.1039/c2ra20684f ↗
60. 10.1016/j.toxlet.2011.11.00210.1016/j.toxlet.2011.11.002 ↗
61. 10.1371/journal.pone.009534010.1371/journal.pone.0095340 ↗
62. 10.1021/es801785m10.1021/es801785m ↗
63. Bury NR · Am J Physiol · 1999 · 277 · 1385
64. 10.1016/S0168-6445(03)00047-010.1016/S0168-6445(03)00047-0 ↗
65. 10.1021/es903555710.1021/es9035557 ↗
66. 10.1021/nl015527410.1021/nl0155274 ↗
67. 10.1016/j.nano.2009.07.00210.1016/j.nano.2009.07.002 ↗
68. 10.1186/1556-276X-9-10110.1186/1556-276X-9-101 ↗
69. 10.1021/nn302649p10.1021/nn302649p ↗
70. Wadhera A · Dermatol Online J · 2005 · 11 · 1210.5070/D30832G6D3 ↗
71. 10.3109/1556365960902024610.3109/15563659609020246 ↗
72. Agency for toxic substances and diseases registry · 1990
73. 10.1248/bpb.16.37210.1248/bpb.16.372 ↗
74. 10.1007/BF0125712010.1007/BF01257120 ↗
75. Luoma SN · 2008
76. 10.1016/j.biomaterials.2004.01.00810.1016/j.biomaterials.2004.01.008 ↗